Data is not available at this time.
Pond Technologies Holdings Inc. operates at the intersection of biotechnology and environmental sustainability, specializing in microalgae cultivation using carbon dioxide emissions from industrial sources. The company's core revenue model combines direct biomass sales with technology licensing, targeting multiple high-value markets including nutraceuticals, aquaculture feed, and pharmaceutical protein expression. As a Canadian agricultural technology firm in the Consumer Defensive sector, Pond leverages proprietary photobioreactor systems to transform waste CO2 into commercial products, positioning itself as an innovative solution provider in the circular economy. The company's strategic focus on leveraging industrial emissions creates a dual-value proposition of environmental impact mitigation and biological manufacturing, though it operates in a capital-intensive niche requiring significant technological validation and market development. Pond's market position remains emergent, competing with established agricultural producers and specialized biotech firms while seeking to demonstrate scalable commercial viability for algae-based products across diverse industrial applications.
For FY 2024, Pond Technologies reported revenue of CAD 2.2 million, indicating early-stage commercial traction in its algae-based product markets. The company operated at a significant net loss of CAD 3.7 million, reflecting the substantial research, development, and operational costs inherent in scaling its proprietary cultivation technology. Negative operating cash flow of CAD 2.0 million underscores the current cash-intensive nature of its business model as it works to establish commercial viability and achieve operational scale.
The company's diluted EPS of -CAD 0.0476 demonstrates ongoing challenges in achieving profitability at its current scale. Minimal capital expenditures of CAD 8,000 suggest a focus on optimizing existing infrastructure rather than significant new investments. The negative cash flow from operations indicates that the business currently consumes rather than generates cash, highlighting the developmental stage of its commercial operations and the need for continued funding to support growth initiatives.
Pond maintains a constrained liquidity position with cash and equivalents of CAD 22,000 against total debt of CAD 6.5 million, creating significant financial leverage. This debt-heavy capital structure, combined with minimal cash reserves, presents substantial refinancing and operational funding challenges. The balance sheet reflects the financial pressures typical of early-stage technology companies in capital-intensive industries, requiring careful cash management and potential additional financing to sustain operations.
As a development-stage company focused on scaling its technology platform, Pond does not pay dividends, reinvesting all available resources into business expansion. The company's growth trajectory depends on successfully commercializing its algae cultivation technology across multiple product verticals and securing additional licensing partnerships. Current financial performance reflects the pre-revenue scaling phase common to innovative agricultural technology ventures pursuing market establishment.
With a market capitalization of approximately CAD 855,922, the market appears to be pricing Pond as an early-stage venture with significant execution risk. The beta of 1.026 suggests stock volatility roughly in line with the broader market. Valuation metrics reflect investor expectations for future technology commercialization success rather than current financial performance, with the modest market cap indicating cautious optimism about the company's long-term potential in sustainable biotechnology.
Pond's primary strategic advantage lies in its proprietary technology for converting industrial carbon emissions into valuable biomass, aligning with growing environmental sustainability trends. The outlook remains challenging given current financial constraints and the need to demonstrate scalable commercial production. Success depends on securing additional funding, expanding licensing partnerships, and achieving operational efficiencies that can transition the business toward profitability while capitalizing on increasing demand for sustainable agricultural and pharmaceutical inputs.
Company financial statementsTSXV filingsBloomberg
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |